Latest Funding News

Polymetals Resources has raised $34.4 million through a share placement to boost exploration and production at its Endeavor Silver Zinc Mine, attracting strong institutional demand.

Microba Life Sciences has secured a $3.06 million R&D tax incentive refund for FY25, reinforcing its cash reserves and supporting ongoing advancements in gastrointestinal diagnostics and clinical therapeutics.

QuickFee Limited has completed a $28.5 million capital return following the sale of its US Pay Now and Connect businesses, while updating its dividend policy to target regular shareholder cash distributions starting in FY26.

Control Bionics Limited is set to acquire the remaining stake in Neuro Elite Athletics, integrating the NeuroBounce athletic performance program with its EMG technology to accelerate growth in key markets.

Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.

Noronex Limited has received a non-refundable $200,000 option fee from Joint Era Mining, moving forward the $4.5 million sale of its Witvlei Project in Namibia and setting a three-month exclusivity period for due diligence.

Rox Resources has opened a $10 million Share Purchase Plan at a 19.9% discount, inviting eligible shareholders to invest in the development of its Youanmi Gold Project. The offer runs through mid-December, aiming to bolster exploration and working capital.

MEC Resources Ltd has announced a placement of over 359 million new options to raise approximately $359,000, with directors participating to offset fees. The offer comes as the company navigates ongoing legal challenges related to its key PEP-11 permit.

SolGold plc has unanimously rejected a non-binding acquisition proposal from Jiangxi Copper, triggering a notable share price rally that has significantly enhanced DGR Global’s valuation as a major SolGold shareholder.

Galilee Energy Limited has been reinstated to trading on the ASX following the announcement of a significant capital raising and acquisition, signaling a pivotal moment for the energy explorer.

Galilee Energy has secured an option to acquire the Zydeco Gas Project in Louisiana, marking a strategic expansion into the US market, supported by a A$6.5 million capital raise to accelerate development.

Biotron Limited has completed a $1 million placement to fund the development of its newly acquired Sedarex Limited assets, marking a strategic expansion of its antiviral portfolio.